Alegret M - Search Results

1

Progressive supranuclear palsy: earlier age of onset in patients with the tau protein A0/A0 genotype.

Molinuevo JL, Valldeoriola F, Alegret M, Oliva R, Tolosa E. Molinuevo JL, et al. Among authors: alegret m. J Neurol. 2000 Mar;247(3):206-8. doi: 10.1007/s004150050564. J Neurol. 2000. PMID: 10787116

2

Cognitive and behavioral changes after unilateral posteroventral pallidotomy: relationship with lesional data from MRI.

Junqué C, Alegret M, Nobbe FA, Valldeoriola F, Pueyo R, Vendrell P, Tolosa E, Rumià J, Mercader JM. Junqué C, et al. Among authors: alegret m. Mov Disord. 1999 Sep;14(5):780-9. doi: 10.1002/1531-8257(199909)14:5<780::aid-mds1010>3.0.co;2-g. Mov Disord. 1999. PMID: 10495039

3

Effects of unilateral posteroventral pallidotomy on 'on-off' cognitive fluctuations in Parkinson's disease.

Alegret M, Vendrell P, Junqué C, Valldeoriola F, Nobbe FA, Rumià J, Tolosa E. Alegret M, et al. Neuropsychologia. 2000;38(5):628-33. doi: 10.1016/s0028-3932(99)00105-0. Neuropsychologia. 2000. PMID: 10689039 Clinical Trial.

4

Obsessive-compulsive symptoms in Parkinson's disease.

Alegret M, Junqué C, Valldeoriola F, Vendrell P, Martí MJ, Tolosa E. Alegret M, et al. J Neurol Neurosurg Psychiatry. 2001 Mar;70(3):394-6. doi: 10.1136/jnnp.70.3.394. J Neurol Neurosurg Psychiatry. 2001. PMID: 11181867 Free PMC article.

5

MRI atrophy parameters related to cognitive and motor impairment in Parkinson's disease.

Alegret M, Junqué C, Pueyo R, Valldeoriola F, Vendrell P, Tolosa E, Mercader JM. Alegret M, et al. Neurologia. 2001 Feb;16(2):63-9. Neurologia. 2001. PMID: 11257931

6

Effects of bilateral subthalamic stimulation on cognitive function in Parkinson disease.

Alegret M, Junqué C, Valldeoriola F, Vendrell P, Pilleri M, Rumià J, Tolosa E. Alegret M, et al. Arch Neurol. 2001 Aug;58(8):1223-7. doi: 10.1001/archneur.58.8.1223. Arch Neurol. 2001. PMID: 11493162

7

Cognitive effects of unilateral posteroventral pallidotomy: a 4-year follow-up study.

Alegret M, Valldeoriola F, Tolosa E, Vendrell P, Junqué C, Martínez J, Rumià J. Alegret M, et al. Mov Disord. 2003 Mar;18(3):323-328. doi: 10.1002/mds.10329. Mov Disord. 2003. PMID: 12621637

8

Comparative cognitive effects of bilateral subthalamic stimulation and subcutaneous continuous infusion of apomorphine in Parkinson's disease.

Alegret M, Valldeoriola F, Martí M, Pilleri M, Junqué C, Rumià J, Tolosa E. Alegret M, et al. Mov Disord. 2004 Dec;19(12):1463-9. doi: 10.1002/mds.20237. Mov Disord. 2004. PMID: 15390065

9

Cognitive changes in Parkinson's disease during subthalamic stimulation: a clinicopathologic study.

Valldeoriola F, Tolosa E, Alegret M, Tolosa E, Rey MJ, Morsi O, Pilleri M, Rumià J. Valldeoriola F, et al. Among authors: alegret m. J Neurol Neurosurg Psychiatry. 2006 Apr;77(4):565-6. doi: 10.1136/jnnp.2005.077990. J Neurol Neurosurg Psychiatry. 2006. PMID: 16543547 Free PMC article. No abstract available.

10

Decreased frontal choline and neuropsychological performance in preclinical Huntington disease.

Gómez-Ansón B, Alegret M, Muñoz E, Sainz A, Monte GC, Tolosa E. Gómez-Ansón B, et al. Among authors: alegret m. Neurology. 2007 Mar 20;68(12):906-10. doi: 10.1212/01.wnl.0000257090.01107.2f. Neurology. 2007. PMID: 17372125

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

218 results

Search Page

Filters